These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 11273362

  • 1. Clinical resistance to ciprofloxacin in Salmonella typhi.
    Rodrigues C, Mehta A, Andrews R, Joshi VR.
    J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
    [No Abstract] [Full Text] [Related]

  • 2. Enteric fever treatment failures: a global concern.
    Chandel DS, Chaudhry R.
    Emerg Infect Dis; 2001 Mar; 7(4):762-3. PubMed ID: 11585550
    [No Abstract] [Full Text] [Related]

  • 3. A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi.
    Alsoub H, Uwaydah AK, Matar I, Zebeib M, Elhag KM.
    Br J Clin Pract; 1997 Mar; 51(1):8-10. PubMed ID: 9158264
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.
    BMC Infect Dis; 2004 Sep 20; 4():36. PubMed ID: 15380025
    [Abstract] [Full Text] [Related]

  • 6. A case of ciprofloxacin-resistant typhoid fever.
    Umasankar S, Wall RA, Berger J.
    Commun Dis Rep CDR Rev; 1992 Nov 06; 2(12):R139-40. PubMed ID: 1284936
    [No Abstract] [Full Text] [Related]

  • 7. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM, Seema DS, Bhat GK, Shivananda PG.
    Indian J Pathol Microbiol; 2001 Oct 06; 44(4):407-8. PubMed ID: 12035350
    [No Abstract] [Full Text] [Related]

  • 8. Multidrug-resistant Salmonella typhi in India.
    Chitnis V, Chitnis D, Verma S, Hemvani N.
    Lancet; 1999 Aug 07; 354(9177):514-5. PubMed ID: 10465202
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
    Gupta LK, Randhawa VS.
    Indian J Med Microbiol; 2008 Aug 07; 26(4):406. PubMed ID: 18974511
    [No Abstract] [Full Text] [Related]

  • 11. [What does it mean 'sensitive'? Failing ciprofloxacin in typhus abdominalis].
    van 't Wout JW, Jones JO, Visser LG, Bijlmer HA, Veldkamp PJ, van Dissel JT.
    Ned Tijdschr Geneeskd; 2009 May 09; 153(19):914-8. PubMed ID: 19489296
    [No Abstract] [Full Text] [Related]

  • 12. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
    Gupta V, Kaur J.
    Int J Infect Dis; 2008 Nov 09; 12(6):e143-4. PubMed ID: 18514007
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multi-resistant typhoid fever.
    Bhattacharya SK, Dutta D, Bhattacharya MK, Rasaily R, Dutta P, Saha A, Saha MR, Pal SC.
    Natl Med J India; 1992 Nov 09; 5(1):41. PubMed ID: 1304255
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of enteric fever--what next?
    Misra S, Thapa BR, Panigrahi D, Mehta S.
    Indian Pediatr; 1991 Apr 09; 28(4):433-5. PubMed ID: 1752667
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection].
    Akin K, Yavuzdemir S, Cesur S, Levent B, Esen B, Willke A.
    Mikrobiyol Bul; 2005 Jan 09; 39(1):83-7. PubMed ID: 15900841
    [Abstract] [Full Text] [Related]

  • 18. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH, Khan MA.
    J Coll Physicians Surg Pak; 2008 Jan 09; 18(1):13-6. PubMed ID: 18452661
    [Abstract] [Full Text] [Related]

  • 19. Emerging drug resistance and vaccination for typhoid fever.
    Atkins BL, Gottlieb T.
    JAMA; 1998 Feb 25; 279(8):579; author reply 580. PubMed ID: 9486743
    [No Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
    Rodrigues C, Kumar NJ, Lalwani J, Mehta A.
    Indian J Med Microbiol; 2009 Feb 25; 27(3):276. PubMed ID: 19584518
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.